Medications listed are available on OH EPIC Formulary, unless otherwise noted. Not all formulary medications are available at each facility. Please refer to your local pharmacy for available inventory.
Releuko is the OH-preferred filgrastim biosimilar for all indications for adults and pediatrics EXCEPT:
Stem cell mobilization prior to (bone marrow) stem cell transplant
Colony stimulation post stem cell (bone marrow) transplantation
Pediatrics patients < 36 kg or requiring intravenous growth factor administration
If a filgrastim biosimilar/tbo-filgrastim (Granix) is ordered for one of the above exceptions, please initiate therapeutic interchange to filgrastim (Neupogen) at the same ordered dose.
If filgrastim (Neupogen), tbo-filgrastim (Granix), or any other filgrastim biosimilar is ordered besides filgrastim- AYOW (Releuko) for an indication not on the above list, please initiate the therapeutic interchange to filgrastim-AYOW (Releuko) at the same ordered dose.
Outpatient formulary:
Releuko is the OH-preferred filgrastim biosimilar. However, it is also driven by payer preference.
Therapeutic Interchange:
Requested
Dispensed
Exceptions:
filgrastim (Neupogen)
filgrastim-AYOW (Releuko)
Stem cell mobilization prior to (bone marrow) stem cell transplant
Colony stimulation post stem cell (bone marrow) transplantation
Pediatrics patients < 36 kg or requiring intravenous growth factor administration
Restricted:
If a filgrastim biosimilar/tbo-filgrastim (Granix) is ordered for one of the above exceptions, please initiate therapeutic interchange to filgrastim (Neupogen) at the same ordered dose.
If filgrastim (Neupogen), tbo-filgrastim (Granix), or any other filgrastim biosimilar is ordered besides filgrastim- AYOW (Releuko) for an indication not on the above list, please initiate the therapeutic interchange to filgrastim-AYOW (Releuko) at the same ordered dose.
Therapeutic Interchange:
Exceptions: